Brussels, 29/01/2015 (Agence Europe) - On Wednesday 28 January, the European Commission gave its conditional authorisation to the planned acquisition of the 'vaccines' division of Novartis (Switzerland) by GlaxoSmithKline (GSK, United Kingdom) and the plan to create a new entity bringing together the activities of the two companies in the consumer healthcare products sector.
Both companies are active worldwide in the research, production and supply of pharmaceutical products and consumer...